GEN1078 DP clinical trials

First-in-Human, Open-Label, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of GEN1078 in Subjects With Malignant Solid Tumors

This early-stage study is testing a new drug called GEN1078 for adults with different types of solid cancers. Researchers want to find out if it's safe, what dose works best, and if it can shrink tumors or stop them from growing.